Cargando…

Immunological recovery in tuberculosis/HIV co-infected patients on antiretroviral therapy: implication for tuberculosis preventive therapy

BACKGROUND: Understanding the immune response to combination antiretroviral therapy (cART) is essential for a clear approach to tuberculosis (TB) preventive therapy. We investigated the immunological recovery in cART-treated HIV-infected patients developing TB compared to those who remained free of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karo, Basel, Krause, Gérard, Castell, Stefanie, Kollan, Christian, Hamouda, Osamah, Haas, Walter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526303/ https://www.ncbi.nlm.nih.gov/pubmed/28743248 http://dx.doi.org/10.1186/s12879-017-2627-y

Ejemplares similares

Tuberculosis among people living with HIV/AIDS in the German ClinSurv HIV Cohort: long-term incidence and risk factors
por: Karo, Basel, et al.
Publicado: (2014)

HIV-Prevalence in Tuberculosis Patients in Germany, 2002–2009: An Estimation Based on HIV and Tuberculosis Surveillance Data
por: Fiebig, Lena, et al.
Publicado: (2012)

Completeness of tuberculosis case notifications in Germany in 2013–2017: first results of an inventory study
por: Domaszewska, Teresa, et al.
Publicado: (2020)

Seasonality in extra-pulmonary tuberculosis notifications in Germany 2004-2014- a time series analysis
por: Charles, Tanja, et al.
Publicado: (2021)

Duration of Anti-Tuberculosis Therapy and Timing of Antiretroviral Therapy Initiation: Association with Mortality in HIV-Related Tuberculosis
por: Cortes, Claudia P., et al.
Publicado: (2013)

Harnessing the Prevention Benefits of Antiretroviral Therapy to Address HIV and Tuberculosis
por: Granich, Reuben, et al.
Publicado: (2011)

The denominator problem: Estimating MSM-specific incidence of sexually transmitted infections and prevalence of HIV using population sizes of MSM derived from Internet surveys
por: Marcus, Ulrich, et al.
Publicado: (2009)

Incidence of active tuberculosis among people living with HIV receiving long‐term antiretroviral therapy in high TB/HIV burden settings in Thailand: implication for tuberculosis preventive therapy
por: Suwanpimolkul, Gompol, et al.
Publicado: (2022)

Complications of Antiretroviral Therapy Initiation in Hospitalised Patients with HIV-Associated Tuberculosis
por: van der Plas, Helen, et al.
Publicado: (2013)

The rise and fall of tuberculosis in Malawi: associations with HIV infection and antiretroviral therapy
por: Kanyerere, Henry, et al.
Publicado: (2015)

Are routine tuberculosis programme data suitable to report on antiretroviral therapy use of HIV-infected tuberculosis patients?
por: Brouwer, Miranda, et al.
Publicado: (2013)

Treatment of HIV among tuberculosis patients: A replication study of timing of antiretroviral therapy for HIV-1-associated tuberculosis
por: Djimeu, Eric W., et al.
Publicado: (2019)

From pills to patients: an evaluation of data sources to determine the number of people living with HIV who are receiving antiretroviral therapy in Germany
por: Schmidt, Daniel, et al.
Publicado: (2015)

Antiretroviral Therapy for Control of the HIV-associated Tuberculosis Epidemic in Resource-Limited Settings
por: Lawn, Stephen D., et al.
Publicado: (2009)

HIV-infected presumptive tuberculosis patients without tuberculosis: How many are eligible for antiretroviral therapy in Karnataka, India?
por: Kumar, Ajay M.V., et al.
Publicado: (2017)

KIR-HLA Genotypes in HIV-Infected Patients Lacking Immunological Recovery despite Effective Antiretroviral Therapy
por: Soria, Alessandro, et al.
Publicado: (2011)

Beneficial Effect of Isoniazid Preventive Therapy and Antiretroviral Therapy on the Incidence of Tuberculosis in People Living with HIV in Ethiopia
por: Yirdaw, Kesetebirhan Delele, et al.
Publicado: (2014)

Everything counts - a method to determine viral suppression among people living with HIV using longitudinal data for the HIV care continuum - results of two large, German, multi-center real-life cohort studies over 20 years (1999–2018)
por: Schmidt, Daniel, et al.
Publicado: (2021)

Poor immunological recovery among severely immunosuppressed antiretroviral therapy-naïve Ugandans
por: Nanzigu, Sarah, et al.
Publicado: (2013)

Antiretroviral Therapy for Prevention of Tuberculosis in Adults with HIV: A Systematic Review and Meta-Analysis
por: Suthar, Amitabh B., et al.
Publicado: (2012)

Prevalence of Pulmonary Tuberculosis Among HIV Positive Patients Attending Antiretroviral Therapy Clinic
por: Giri, Purushottam A, et al.
Publicado: (2013)

Incidence of tuberculosis in HIV-infected adults on first- and second-line antiretroviral therapy in India
por: Gupte, Akshay N., et al.
Publicado: (2019)

Incidence of and risk factors for tuberculosis among people with HIV on antiretroviral therapy in the United Kingdom
por: van Halsema, Clare L., et al.
Publicado: (2020)

Risk of Mycobacterium tuberculosis transmission in an antiretroviral therapy clinic
por: Mzembe, Themba, et al.
Publicado: (2018)

Presentation and healthcare delays among people with tuberculosis in London, and the impact on treatment outcome
por: Evenden, Poppy, et al.
Publicado: (2019)

Timing of antiretroviral therapy and regimen for HIV-infected patients with tuberculosis: the effect of revised HIV guidelines in Malawi
por: Tweya, Hannock, et al.
Publicado: (2014)

Impaired CD4-cell immune reconstitution upon HIV therapy in patients with toxoplasmic encephalitis compared to patients with pneumocystis pneumonia as AIDS indicating disease
por: Kastenbauer, U, et al.
Publicado: (2009)

Integrated therapy for HIV and tuberculosis
por: Manosuthi, Weerawat, et al.
Publicado: (2016)

Incidence and mortality of tuberculosis before and after initiation of antiretroviral therapy: an HIV cohort study in India
por: Alvarez-Uria, Gerardo, et al.
Publicado: (2014)

Active Tuberculosis Is Associated with Worse Clinical Outcomes in HIV-Infected African Patients on Antiretroviral Therapy
por: Siika, Abraham M., et al.
Publicado: (2013)

Tuberculosis treatment intermittency in the continuation phase and mortality in HIV-positive persons receiving antiretroviral therapy
por: Crabtree-Ramirez, Brenda, et al.
Publicado: (2022)

Calculation of Direct Antiretroviral Treatment Costs and Potential Cost Savings by Using Generics in the German HIV ClinSurv Cohort
por: Stoll, Matthias, et al.
Publicado: (2011)

Immunology of Tuberculosis
por: Bozzano, Federica, et al.
Publicado: (2014)

Hepatitis B and C infections in HIV-1 patients on combination antiretroviral therapy (cART) in Ghana: implications for immunologic recovery, clinical response to treatment, and hepatotoxicity
por: Kwofie, Theophilus Benjamin, et al.
Publicado: (2021)

Immunological failure despite virological suppression in HIV seropositive individuals on antiretroviral therapy
por: Prabhakar, B., et al.
Publicado: (2011)

Prevalence of Tuberculosis, HIV and Respiratory Symptoms in Two Zambian Communities: Implications for Tuberculosis Control in the Era of HIV
por: Ayles, Helen, et al.
Publicado: (2009)

Antiretroviral therapy at a district hospital in Ethiopia prevents death and tuberculosis in a cohort of HIV patients
por: Jerene, Degu, et al.
Publicado: (2006)

Early versus delayed initiation of antiretroviral therapy for Indian HIV-Infected individuals with tuberculosis on antituberculosis treatment
por: Sinha, Sanjeev, et al.
Publicado: (2012)

Drug-Resistant Tuberculosis among HIV-Infected Patients Starting Antiretroviral Therapy in Durban, South Africa
por: Hom, Jeffrey K., et al.
Publicado: (2012)

Pregnancy Outcomes in HIV-Infected Women Receiving Long-Term Isoniazid Prophylaxis for Tuberculosis and Antiretroviral Therapy
por: Taylor, Allan W., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_07d40bknb51jlpjkdjnhoecucp